Latest News for: hlb

Edit

Budget 2027 to strengthen enterprises, productivity and household wellbeing — HLB

The Edge Malaysia 10 Oct 2026
“Our flagship financial literacy programmes, HLB DuitSmart and HLB @ School, empower students and young Malaysians with essential money management skills, building strong foundations for lifelong financial wellbeing,” it said.
Edit

HLB's Bile Duct Drug Enters European Review

Chosun Ilbo 07 Oct 2026
Following the formal approval of HLB’s bile duct cancer drug Lirafugratinib by the U.S ... HLB’s U.S ... HLB expects that with the commencement of the approval process in Europe following the U.S., the global ...
Edit

HLB Shares Surge 23% on U.S. Drug Approval Progress

Chosun Ilbo 06 Oct 2026
HLB's stock surged 23% on October 6 ... At the same time, its affiliates HLB Pharmaceutical (29.97%), HLB BioStep (29.91%), and HLB Life Science (27.27%) were also experiencing sharp gains. HLB’s U.S.
Edit

HLB resolves issues behind FDA setback for novel liver cancer drug

Korea Times 15 Jul 2026
Food and Drug Administration (FDA) has determined that the inspection findings behind its rejection of HLB's liver cancer drug Rivoceranib can be addressed through voluntary corrective actions, easing market concerns over the treatment.
Edit

HLB Life Science secures 5th state grant to develop medical hemp therapies

Korea Times 06 Jul 2026
HLB Life Science R&D, the research and development subsidiary of HLB, a prominent Korean life sciences conglomerate, has been selected for its fifth government-backed research project this year, according to the firm.
  • 1
×